Results

1–9 of 9 results for Roger A. Goldberg

Early vs Delayed Pegcetacoplan Treatment for GA Secondary to AMD: 48-Month Results From OAKS, DERBY,and GALE Open-Label Extension
Roger A. Goldberg, MD, MBA
Annual Meeting Talks
2025
Exudative Age-Related Macular Degeneration Events from the OAKS and DERBY Clinical Trials of Pegcetacoplan in Geographic Atrophy
Roger A. Goldberg, MD, MBA
Annual Meeting Talks
2023
Real-World Impact of Early Treatment With Intravitreal Dexamethasone Implant in DME in US Clinical Practice: Outcomes From the Vestrum Database
Roger A. Goldberg, MD, MBA
On Demand Cases, Courses, and Papers
2021
Erosion of Segmental Buckle
Roger A. Goldberg, MD, MBA
Retina Image Bank: Images of the Week
2022
Particulate Matter From Syringes Used for Intravitreal Injections
Roger A. Goldberg, MD, MBA
Annual Meeting Talks
2020
What Happens to Diabetic Retinopathy Severity Scores With Less Aggressive Treatment? A Post Hoc Analysis of the RISE and RIDE Open Label Extension Study
Roger A. Goldberg, MD, MBA
Updates from the Field
2019
What Happens to Diabetic Retinopathy Severity Scores With Less Aggressive Treatment? A Post Hoc Analysis of the RISE and RIDE Open Label Extension Study
Roger A. Goldberg, MD, MBA
Annual Meeting Talks
2019
What Happens to Diabetic Retinopathy Severity Scores With Less Aggressive Treatment? A Post Hoc Analysis of the RISE and RIDE Open Label Extension Study
Roger A. Goldberg, MD, MBA
Updates from the Field
2019
Short-term Oral Mifepristone for the Treatment of Central Serous Chorioretinopathy (STOMP-CSC): A Placebo-Controlled Clinical Trial
Roger A. Goldberg, MD, MBA
Annual Meeting Talks
2018